Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Methitest

Generic name: Methyltestosterone

FDA application holder: Impax Labs

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Methitest?
Methitest is a brand name of Methyltestosterone, a prescription medicine. The FDA NDC Directory lists 1 Methitest product in 1 strength and form.
Who makes Methitest?
Impax Labs holds the FDA application for Methitest (ANDA080767, approved October 17, 1974).
Is there a generic or store brand of Methitest?
Other products of Methyltestosterone are listed with the FDA, but none in exactly the same strength and form as a Methitest product.
Has Methitest been recalled?
No recall linked to Methitest products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Methitest is

Each Methitest product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Methyltestosterone · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
methyltestosterone 10 mg
tablet (oral)
Methitest None listed DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Methyltestosterone →

FDA approval

  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
FDA applications of Methitest products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
ANDA080767Impax LabsOctober 17, 19741

Companies that list Methitest

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Methitest products.

Recalls

No recall linked to Methitest products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers